#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dermatitis atopic Breast cancer metastatic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Hypochromic anaemia Acquired haemophilia Juvenile psoriatic arthritis Pulmonary fibrosis B precursor type acute leukaemia Hereditary angioedema Squamous cell carcinoma of the vulva Toxic epidermal necrolysis Paraneoplastic neurological syndrome Hereditary optic atrophy Diabetes insipidus Optic glioma Hereditary ataxia Primary mediastinal large B-cell lymphoma Hepatocellular carcinoma More trials…

    Learn about Rare Diseases

    Pituitary-dependent Cushing’s syndrome – Basic Information Leiomyosarcoma Urea cycle disorder – Treatment Haemophilia A without inhibitors X-linked lymphoproliferative syndrome – Basic Information Castleman’s disease – Treatment Atypical haemolytic uraemic syndrome – Trials in Disease Alagille syndrome Phenylketonuria Systemic sclerosis pulmonary – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Ecopipam Hydrochloride Nizaracianine Triflutate Elezanumab Calcium Levofolinate Quercus Ilex Allergen Extract CHONDROITIN SULFATE SODIUM Risankizumab Cat Epithelia Kyv-101 Ramucirumab Lavender Oil Pralatrexate Trimetazidine Dihydrochloride Niraparib Tosilate Monohydrate AMODIAQUINE Sodium Chloride HYDROGEN PEROXIDE Paltusotine Ace Inhibitors, Plain Edotreotide More therapies…

    Learn about Your Condition

    Autoimmune disorder Perinatal depression Frostbite Exudative retinopathy Venous thrombosis Cough Colorectal cancer stage IV Epicondylitis Hepatic cancer Open angle glaucoma Langerhans cell sarcoma Heart disease congenital Rett syndrome Basal cell carcinoma Biliary neoplasm More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Study on Alkaline Phosphatase to Prevent Inflammation and Kidney Injury in Patients Undergoing Open-Heart Surgery

    Not yet recruiting

    3 1
    Investigated Diseases:
    • Cardiac function disturbance postoperative
    Investigated Drugs:
    • Alkaline Phosphatase, Bovine
    Austria Belgium

  • Study Comparing Dabigatran Etexilate, Acetylsalicylic Acid, and Clopidogrel for Preventing Blood Clots in Patients with Atrial Fibrillation After Heart Procedure

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Atrial fibrillation
    Investigated Drugs:
    • Dabigatran Etexilate
    • Clopidogrel
    • Rivaroxaban
    Spain

  • Study on Stopping Allopurinol or Febuxostat in Gout Patients in Remission

    Not yet recruiting

    2 1 1 1
    Investigated Drugs:
    • Allopurinol
    • Febuxostat
    France

  • Study on Optimizing Immunosuppressive Treatment for Living Donor Kidney Transplant Patients Using Prednisone, Basiliximab, and Tacrolimus Monohydrate

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Renal transplant
    Investigated Drugs:
    • Basiliximab
    • Tacrolimus Monohydrate
    • Methylprednisolone
    Spain

  • Study on the Effects of Tepotinib and Cetuximab for Patients with Platinum-Resistant Head and Neck Cancer After Immunotherapy Relapse

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Head and neck cancer
    Investigated Drugs:
    • Cetuximab
    • Tepotinib
    Italy

  • Study on the Effect of Tinzaparin Sodium on Survival in Patients with Advanced Pancreatic Cancer

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Thrombosis
    • Tumour thrombosis
    Investigated Drugs:
    • Tinzaparin Sodium
    Greece
Previous Page
1 … 819 820 821 822 823 … 1,657
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!